Novelion Therapeutics Inc (NVLNF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 45,154 | 55,430 | 109,317 | 141,824 | 155,908 |
| Receivables | 28,912 | 22,191 | 31,339 | 287 | 410 |
| Inventories | 12,745 | 15,886 | 15,718 | N/A | N/A |
| TOTAL | $102,543 | $104,943 | $166,136 | $142,736 | $157,371 |
| Non-Current Assets | |||||
| PPE Net | 1,585 | 2,920 | 4,159 | 430 | 1,000 |
| Intangibles | 200,176 | 225,272 | 250,324 | 0 | 0 |
| Other Non-Current Assets | 37,411 | 36,187 | 60,163 | 2,000 | 2,000 |
| TOTAL | $239,172 | $264,379 | $314,646 | $2,430 | $3,000 |
| Total Assets | $341,715 | $369,322 | $480,782 | $145,166 | $160,371 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 348,492 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 6,012 | 13,800 | 17,609 | 1,656 | 1,943 |
| Accrued Expenses | 44,195 | 41,838 | 37,180 | 1,827 | 1,528 |
| Other current liabilities | 11,689 | 8,596 | 64,010 | N/A | N/A |
| TOTAL | $410,388 | $64,234 | $118,799 | $3,483 | $3,471 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 20,187 | 290,150 | 226,196 | 342 | 388 |
| TOTAL | $20,187 | $290,150 | $226,196 | $342 | $388 |
| Total Liabilities | $430,575 | $354,384 | $344,995 | $3,825 | $3,859 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | N/A | N/A | 10,566 | 10,251 |
| Common Shares | 552,506 | 551,925 | 551,259 | 475,333 | 467,034 |
| Retained earnings | -822,301 | -713,974 | -587,208 | -534,338 | -511,329 |
| Other shareholders' equity | 101,640 | 103,802 | 102,587 | 102,969 | 102,969 |
| TOTAL | $-88,860 | $14,938 | $135,787 | $141,341 | $156,512 |
| Total Liabilities And Equity | $341,715 | $369,322 | $480,782 | $145,166 | $160,371 |